2011•Current Oncology ReportsOpen access

Bevacizumab in the Treatment of Metastatic Breast Cancer: Friend or Foe?

Alberto J. Montero, Mauricio A. Escobar, Gilberto Lopes, Stefan Glück, Charles L. Vogel

Open full text 92 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 92 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Bevacizumab, Medicine, Metastatic breast cancer, Oncology, Internal medicine, Paclitaxel, Breast cancer, Vascular endothelial growth factor

Back to paper search Browse research topics Original source

Bevacizumab in the Treatment of Metastatic Breast Cancer: Friend or Foe? — Research Paper | ScholarLens